These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35659782)

  • 1. In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication.
    Favi E; Signorini L; Villani S; Dolci M; Ticozzi R; Basile G; Ferrante P; Ferraresso M; Delbue S
    Transplant Proc; 2022 Sep; 54(7):2035-2041. PubMed ID: 35659782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.
    Hirsch HH; Yakhontova K; Lu M; Manzetti J
    Am J Transplant; 2016 Mar; 16(3):821-32. PubMed ID: 26639422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J; Hill P; Goodman D
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Leflunomide as an Antiviral Agent with Everolimus for BK Virus Nephropathy Patients After Kidney Transplantation: A Case Series.
    Yamazaki T; Shirai H; Tojimbara T
    Am J Case Rep; 2020 Nov; 21():e927367. PubMed ID: 33235184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen.
    Suwelack B; Malyar V; Koch M; Sester M; Sommerer C
    Transplant Rev (Orlando); 2012 Jul; 26(3):201-11. PubMed ID: 21940156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
    Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
    Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
    Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
    Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors of BK Virus Development in Kidney Transplant Recipients and the Effect of Low-Dose Tacrolimus Plus Everolimus on Clinical Outcomes.
    Yilmaz VT; Kisaoglu A; Avanaz A; Dandin O; Ozel D; Mutlu D; Akkaya B; Aydinli B; Kocak H
    Exp Clin Transplant; 2023 Sep; 21(9):727-734. PubMed ID: 37885288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies against BK polyomavirus infection in kidney transplant recipients: Systematic review and meta-analysis.
    Zhong C; Chen J; Yan Z; Xia R; Zeng W; Deng W; Xu J; Wang Y; Miao Y
    Transpl Immunol; 2023 Dec; 81():101953. PubMed ID: 37931665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.
    Kotton CN; Kamar N; Wojciechowski D; Eder M; Hopfer H; Randhawa P; Sester M; Comoli P; Tedesco Silva H; Knoll G; Brennan DC; Trofe-Clark J; Pape L; Axelrod D; Kiberd B; Wong G; Hirsch HH;
    Transplantation; 2024 Sep; 108(9):1834-1866. PubMed ID: 38605438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.
    van Doesum WB; Gard L; Bemelman FJ; de Fijter JW; Homan van der Heide JJ; Niesters HG; van Son WJ; Stegeman CA; Groen H; Riezebos-Brilman A; Sanders JSF
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28258601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment for BK Virus Nephropathy by Leflunomide in a Kidney Transplant Patient: A Case Report.
    Wu MY; Chen YW; Hung LY; Lee CH; Chen HA; Hsu YH; Wu MS
    Transplant Proc; 2019 Jun; 51(5):1472-1474. PubMed ID: 31084921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection.
    Liacini A; Seamone ME; Muruve DA; Tibbles LA
    Transplantation; 2010 Dec; 90(12):1450-7. PubMed ID: 21079551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Hirsch HH; Randhawa PS;
    Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.